China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

The Russian Operation Using AI Fakes to Target Voters
19:25

Modi Is More Powerful Than Ever — Even as India’s Economy Strains
19:19

Federal Reserve Chair Jerome Powell’s Legacy
20:37